CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,184,749 | -12.2% | 43,485 | -28.3% | 0.60% | -6.3% |
| Q2 2023 | $1,349,062 | +2.8% | 60,632 | +0.1% | 0.64% | -2.9% |
| Q1 2023 | $1,312,531 | +106177.8% | 60,597 | -0.4% | 0.66% | +3.8% |
| Q4 2022 | $1,235 | -99.9% | 60,824 | -0.7% | 0.63% | -26.5% |
| Q3 2022 | $1,571,000 | -21.2% | 61,254 | -26.9% | 0.86% | -18.2% |
| Q2 2022 | $1,993,000 | +5.4% | 83,818 | -0.2% | 1.05% | +19.2% |
| Q1 2022 | $1,891,000 | +13.2% | 83,967 | -0.5% | 0.88% | +28.3% |
| Q4 2021 | $1,671,000 | +0.6% | 84,408 | -0.0% | 0.69% | -8.5% |
| Q3 2021 | $1,661,000 | -29.4% | 84,423 | -21.1% | 0.75% | -6.1% |
| Q2 2021 | $2,353,000 | -10.5% | 106,938 | -3.2% | 0.80% | -7.9% |
| Q1 2021 | $2,629,000 | -10.0% | 110,512 | -1.0% | 0.87% | -21.4% |
| Q4 2020 | $2,920,000 | +48.8% | 111,639 | -1.0% | 1.11% | +18.2% |
| Q3 2020 | $1,963,000 | +28.5% | 112,798 | +24.1% | 0.94% | +33.7% |
| Q2 2020 | $1,528,000 | – | 90,860 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |